Efficacy of 851B Gel for Treating High-Risk Cervical Human Papillomavirus Infection in Women.
Condition(s):Papillomavirus InfectionsLast Updated:September 23, 2016Terminated
Hide Studies Not Open or Pending
Condition(s):Papillomavirus InfectionsLast Updated:September 23, 2016Terminated
Condition(s):Healthy Subject; Human Papillomavirus InfectionLast Updated:August 1, 2019Withdrawn
Condition(s):Nonneoplastic Condition; Precancerous ConditionLast Updated:October 5, 2015Completed
Condition(s):Papillomavirus InfectionsLast Updated:August 19, 2016Terminated
Condition(s):Human Papilloma VirusLast Updated:October 10, 2023Recruiting
Condition(s):Human Papillomavirus Infection; Human Immunodeficiency Virus Infection; Sexually Transmitted DiseasesLast Updated:August 8, 2023Not yet recruiting
Condition(s):HPV-Related Cervical CarcinomaLast Updated:September 26, 2019Completed
Condition(s):Papillomavirus Infections; HIV InfectionsLast Updated:January 21, 2016Unknown status
Condition(s):Hiv InfectionLast Updated:December 7, 2020Unknown status
Condition(s):HPV Positive Oropharyngeal Squamous Cell Carcinoma; HIV-1-infection; HPV InfectionLast Updated:August 16, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.